Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 3
1973 1
1974 6
1975 39
1976 48
1977 103
1978 102
1979 159
1980 181
1981 217
1982 227
1983 234
1984 250
1985 262
1986 260
1987 203
1988 233
1989 210
1990 233
1991 249
1992 291
1993 296
1994 282
1995 278
1996 314
1997 295
1998 299
1999 335
2000 395
2001 364
2002 408
2003 450
2004 470
2005 529
2006 566
2007 664
2008 594
2009 647
2010 694
2011 735
2012 754
2013 803
2014 797
2015 721
2016 754
2017 750
2018 740
2019 677
2020 787
2021 839
2022 807
2023 725
2024 314

Text availability

Article attribute

Article type

Publication date

Search Results

19,788 results

Results by year

Filters applied: . Clear all
Page 1
Sodium valproate.
Kupferberg HJ. Kupferberg HJ. Adv Neurol. 1980;27:643-54. Adv Neurol. 1980. PMID: 6769305 Review. No abstract available.
Sodium Valproate-Induced Hyperpigmentation.
Elwadhi A, Neha KC, Gupta D, Sharawat IK, Panda PK. Elwadhi A, et al. J Pediatr. 2023 Dec;263:113660. doi: 10.1016/j.jpeds.2023.113660. Epub 2023 Aug 2. J Pediatr. 2023. PMID: 37541425 No abstract available.
Sodium valproate.
[No authors listed] [No authors listed] Lancet. 1988 Nov 26;2(8622):1229-31. Lancet. 1988. PMID: 2903957 Review. No abstract available.
Combined effects of levetiracetam and sodium valproate on paediatric patients with epilepsy: a systematic review and meta-analysis.
Zhu Y, Yang J, Zhu X. Zhu Y, et al. Seizure. 2022 Feb;95:17-25. doi: 10.1016/j.seizure.2021.12.003. Epub 2021 Dec 21. Seizure. 2022. PMID: 34971912 Free article. Review.
RESULTS: Of 577 original titles screened, data were extracted from 7 studies (617 participants). Compared with sodium valproate alone or sodium valproate combined with topiramate, the application of sodium valproate combined with levetira …
RESULTS: Of 577 original titles screened, data were extracted from 7 studies (617 participants). Compared with sodium valproate …
Sodium valproate.
[No authors listed] [No authors listed] N Z Med J. 1979 Oct 10;90(645):298-9. N Z Med J. 1979. PMID: 117405 No abstract available.
Moving beyond sodium valproate: choosing the right anti-epileptic drug in children.
Balagura G, Iapadre G, Verrotti A, Striano P. Balagura G, et al. Expert Opin Pharmacother. 2019 Aug;20(12):1449-1456. doi: 10.1080/14656566.2019.1617850. Epub 2019 May 17. Expert Opin Pharmacother. 2019. PMID: 31099271 Review.
Introduction: Sodium valproate is a widely used anti-epileptic drug with a broad spectrum of activity and mechanism of action. ...The current alternatives to valproate in absence, myoclonic, tonic-clonic and focal onset seizures in children/adolescents are al …
Introduction: Sodium valproate is a widely used anti-epileptic drug with a broad spectrum of activity and mechanism of action. …
Sodium valproate for the treatment of Tourettes syndrome in children: a systematic review and meta-analysis.
Yang CS, Zhang LL, Lin YZ, Guo Q. Yang CS, et al. Psychiatry Res. 2015 Apr 30;226(2-3):411-7. doi: 10.1016/j.psychres.2014.08.058. Epub 2014 Oct 2. Psychiatry Res. 2015. PMID: 25724485 Review.
Only one RCT (93 patients) evaluated total YGTSS scores and there was significant difference in the reduction of total YGTSS scores between sodium valproate and the control group (3.504.59 vs 7.867.03, P<0.01). ...In conclusion, based on the limited evidence, the …
Only one RCT (93 patients) evaluated total YGTSS scores and there was significant difference in the reduction of total YGTSS scores between …
Sodium valproate (VPA) interactions with DNA and histones.
de Campos Vidal B, Mello MLS. de Campos Vidal B, et al. Int J Biol Macromol. 2020 Nov 15;163:219-231. doi: 10.1016/j.ijbiomac.2020.06.265. Epub 2020 Jun 30. Int J Biol Macromol. 2020. PMID: 32619665
Valproic acid/sodium valproate (VPA) constitutes a widely prescribed drug for the treatment of seizure disorders and is a well-known epigenetic agent, inducing the acetylation of histones and affecting the methylation status of DNA and histones, with c …
Valproic acid/sodium valproate (VPA) constitutes a widely prescribed drug for the treatment of seizure disorders …
An update on sodium valproate.
Rimmer EM, Richens A. Rimmer EM, et al. Pharmacotherapy. 1985 May-Jun;5(3):171-84. doi: 10.1002/j.1875-9114.1985.tb03413.x. Pharmacotherapy. 1985. PMID: 3927267 Review.
Sodium valproate has been in clinical use for the treatment of epilepsy in Great Britain since 1973 and in the United States since 1978. ...The role of therapeutic drug monitoring in the management of patients taking sodium valproate is controversial.. …
Sodium valproate has been in clinical use for the treatment of epilepsy in Great Britain since 1973 and in the United States s …
Valproic acid and sodium valproate for neuropathic pain and fibromyalgia in adults.
Gill D, Derry S, Wiffen PJ, Moore RA. Gill D, et al. Cochrane Database Syst Rev. 2011 Oct 5;2011(10):CD009183. doi: 10.1002/14651858.CD009183.pub2. Cochrane Database Syst Rev. 2011. PMID: 21975791 Free PMC article. Review.
OBJECTIVES: To evaluate the analgesic efficacy and adverse effects of valproic acid and sodium valproate in the management of chronic neuropathic pain and fibromyalgia. ...There is insufficient evidence to support the use of valproic acid …
OBJECTIVES: To evaluate the analgesic efficacy and adverse effects of valproic acid and sodium valproate in the …
19,788 results
You have reached the last available page of results. Please see the User Guide for more information.

Searches related to "sodium valproate"